Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Author: Benzinga Insights | April 25, 2023 09:06am

Gainers

  • Virios Therapeutics (NASDAQ:VIRI) shares moved upwards by 93.5% to $1.21 during Tuesday's pre-market session. The market value of their outstanding shares is at $22.1 million.
  • Baudax Bio (NASDAQ:BXRX) shares moved upwards by 44.14% to $2.71. The company's market cap stands at $7.0 million.
  • Spectrum Pharma (NASDAQ:SPPI) shares increased by 33.36% to $0.92. The market value of their outstanding shares is at $189.0 million.
  • Morphic Holding (NASDAQ:MORF) stock rose 30.94% to $57.0. The market value of their outstanding shares is at $2.2 billion. The company's, Q1 earnings came out today.
  • Petros Pharma (NASDAQ:PTPI) stock moved upwards by 23.95% to $4.76. The company's market cap stands at $9.9 million.
  • Arrowhead Pharma (NASDAQ:ARWR) shares rose 21.58% to $36.5. The market value of their outstanding shares is at $3.9 billion.

Losers

  • TRACON Pharma (NASDAQ:TCON) stock declined by 51.1% to $0.87 during Tuesday's pre-market session. The company's market cap stands at $20.8 million.
  • Vyant Bio (NASDAQ:VYNT) shares decreased by 31.7% to $0.38. The market value of their outstanding shares is at $2.3 million.
  • Nanobiotix (NASDAQ:NBTX) stock declined by 28.98% to $3.04. The company's market cap stands at $105.9 million. As per the press release, FY earnings came out yesterday.
  • MAIA Biotechnology (AMEX:MAIA) stock decreased by 20.23% to $2.17. The company's market cap stands at $23.8 million.
  • Assertio Holdings (NASDAQ:ASRT) shares fell 16.25% to $5.36. The market value of their outstanding shares is at $298.3 million.
  • Day One Biopharmaceutical (NASDAQ:DAWN) shares decreased by 13.94% to $11.8. The company's market cap stands at $868.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ARWR ASRT BXRX DAWN MAIA MORF NBTX PTPI SPPI TCON VIRI VYNT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist